Comment receiving replies
Replies to "I’m going to be doing the 5 fraction SBRT salvage radiation soon. How did it go..."
My SBRT went well. I was worried if I was well prepared for my second treatment; I asked after treatment if there was a problem, I was told that everything went well. On the third session, I was asked if I experience "burning urination." No. However, after I completed all 5 treatments, I noticed some mucus and traces of blood in my stool. I reported to my oncologist but apparently, it wasn't a cause for concern; it cleared after a few days. Regarding ADT, I'm now on 4th month in Orgovyx. My first PSA test will be on July 8, then November. My oncologist will advise if I can be off Orgovyx after 8 or 12 months. I was Gleason 7 (3+4) on three cores out of 14 samples, (0+2) on four, (0,0) on seven, intermediate risk, early stage 2. What was your Gleason score and Stage? Offhand, Jeff indicated yours may be aggressive, reason for recommending two years ADT. I will yield to my oncologist's recommendation, whether 8 or 12 months for me.
Do you want to have a long life? It’s recommended for two years because your cancer is aggressive. If you don’t stick to those two years, you can almost guarantee you’re going to have a reoccurrence.
Cancer can be really painful if you let it grow. Staying on ADT is not going to kill you but stopping It may Shorten your life a lot. I’ve been on ADT for eight years, I don’t like it, but it keeps me alive.
I attend Weekly advanced prostate cancer meetings at Ancan.org. They’ve been giving advice to people who have prostate cancer for 15 years. One thing they have found is that people who do what you are saying you want to do are the ones that live the shortest lives, And have their cancer come back and be aggressive. People come in frequently asking to shorten the amount of time they are on ADT, It’s seldom advisable, Their years of experience helping people have confirmed that fact.
You’ve already had one reoccurrence, Do you really want a second, sooner than it has to be.